Table 3.
Patients' characteristics and outcome of the recurrent cases in the four groups
| Characteristics | Group 1 (n = 42) | Group 2 (n = 23) | Group 3 (n = 72) | Group 4 (n = 70) | |||||
|---|---|---|---|---|---|---|---|---|---|
| No. of recurrent cases | 9 | (21 %) | 13 | (57 %) | 29 | (40 %) | 39 | (56 %) | |
| Recurrence within 1 year | 7 | (17 %) | 9 | (39 %) | 22 | (31 %) | 31 | (44 %) | |
| Median follow-up period (months; range) | 27.8 | (11.1–56.5) | 20.0 | (4.6–62.0) | 30.1 | (5.6–64.5) | 38.2 | (3.7–69.5) | |
| Median age (years; range) | 74.0 | (60–81) | 72.9 | (45–84) | 71.0 | (60–84) | 78.4 | (50–93) | |
| Gender | Male | 8 | (89 %) | 10 | (77 %) | 20 | (69 %) | 27 | (69 %) |
| Female | 1 | (11 %) | 3 | (23 %) | 9 | (31 %) | 12 | (31 %) | |
| Tumor size† | <3 cm | 7 | (78 %) | 5 | (38 %) | 24 | (83 %) | 31 | (79 %) |
| ≥3 cm | 2 | (22 %) | 8 | (62 %) | 5 | (17 %) | 8 | (21 %) | |
| Tumor number† | Single | 4 | (44 %) | 8 | (62 %) | 9 | (31 %) | 23 | (59 %) |
| Multiple | 5 | (56 %) | 5 | (38 %) | 20 | (69 %) | 16 | (41 %) | |
| Concomitant CIS† | Negative | 7 | (78 %) | 13 | (100 %) | 24 | (83 %) | 38 | (97 %) |
| Positive | 2 | (22 %) | 0 | (0 %) | 5 | (17 %) | 1 | (3 %) | |
| EAU recurrence risk† | <9 | 8 | (89 %) | 13 | (100 %) | 25 | (86 %) | 39 | (100 %) |
| ≥10 | 1 | (11 %) | 0 | (0 %) | 4 | (14 %) | 0 | (0 %) | |
| Location of the recurrent tumor†† | Same | 3 | (14 %) | 3 | (23 %) | 20 | (69 %) | 29 | (41 %) |
| Different | 7 | (33 %) | 10 | (77 %) | 12 | (41 %) | 22 | (31 %) | |
| Unknown | 0 | (0 %) | 0 | (0 %) | 1 | (3 %) | 2 | (3 %) | |
| No. of progressed cases who needed radical cystectomy | 3 | (7 %) | 0 | (0 %) | 7 | (10 %) | 4 | (6 %) | |
| Outcome | NED | 9 | (100 %) | 12 | (92 %) | 23 | (79 %) | 31 | (79 %) |
| AWD | 0 | (0 %) | 0 | (0 %) | 4 | (14 %) | 4 | (10 %) | |
| DOD | 0 | (0 %) | 0 | (0 %) | 2 | (7 %) | 2 | (5 %) | |
| DOC | 0 | (0 %) | 1 | (8 %) | 0 | (0 %) | 2 | (5 %) | |
† characteristics of the initial TUR, †† compared with the initial TUR